The acquisition of Enci Therapeutics will advance Innova Therapeutics' lead program, IVT-8086, a humanized monoclonal antibody targeting SFRP2 which is expressed in most solid and hematological ...
Innova Therapeutics Inc., a biotechnology company dedicated to developing innovative cancer therapies for patients who have inadequate treatment options, recently announced that the U.S. Food and Drug ...
ISLE OF PALMS, S.C., Sept. 24, 2020 /PRNewswire/ -- Innova Therapeutics Inc., a biopharmaceutical company committed to developing innovative cancer therapies for patients who have inadequate treatment ...
Innova Therapeutics Inc, a biopharmaceutical company committed to developing innovative cancer therapies for patients who have inadequate treatment options, announced that the US FDA has granted Rare ...
The MarketWatch News Department was not involved in the creation of this content. The acquisition of Enci Therapeutics will advance Innova Therapeutics' lead program, IVT-8086, a humanized monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results